NCT06013618 2025-06-17Clinical Analysis of Naxitamab (hu3F8) in the Treatment of Pediatric High Risk or Refractory/ Relapsed NeuroblastomaSun Yat-sen UniversityPhase 2 Recruiting120 enrolled
NCT05228951 2022-09-13Pyrotinib Maleate, Trastuzumab, SHR6390 and Letrozole in Combination for Stage II-III TPBCShengjing HospitalPhase 2 Recruiting12 enrolled
NCT05206890 2022-01-26A Non-interventional Registry Study of Fluzoparib in the Treatment of Ovarian CancerTongji HospitalRecruiting490 enrolled